e-Library of Evidence for Nutrition Actions (eLENA)

Vitamin A supplementation in HIV-infected infants and children 6–59 months of age

Vitamin A deficiency affects about 190 million preschool-age children, mostly from Africa and South-East Asia. In infants and children, vitamin A is essential to support rapid growth and to help combat infections. Inadequate intakes of vitamin A may lead to vitamin A deficiency that can cause night blindness, may increase the risk of illness and death from childhood infections, and may compound the effects of HIV infection.

Research has shown that vitamin A supplementation in HIV-infected infants and children is safe and effective in reducing illness and death.

Based on the available evidence, in settings where vitamin A deficiency is a public health problem, WHO recommends high-dose vitamin A supplementation for HIV-infected infants and children 6–59 months of age, as a public health intervention to reduce child morbidity and mortality.

WHO documents


GRC-approved guidelines

Evidence


Systematic reviews used to develop the guidelines
Related systematic reviews
Clinical trials
Share

Last update:

25 March 2014 13:35 CET

Category 1 intervention

Guidelines have been recently approved by the WHO Guidelines Review Committee